600584:SSEJCET Group Co., Ltd. Class A Analysis
Data as of 2026-03-17 - not real-time
CN¥43.75
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
JCET Group is trading at CNY 43.75, which sits below its 20‑day (≈46.6) and 50‑day (≈45.3) moving averages but remains above the 200‑day level (≈38.7), indicating a longer‑term bullish bias despite short‑term weakness. The MACD is bearish (line below signal) and the RSI at around 41 points suggests the stock is not yet oversold, while volume is on the rise and the price is hovering just above the identified support of CNY 42.7, with resistance near CNY 50.3.
Fundamentally, the company appears overvalued: a trailing P/E of roughly 53 far exceeds the industry average of 34, and the DCF‑derived fair value (~CNY 36.9) is well below the current price. Margins are thin (gross ~13 %, operating ~6 %) and free cash flow is negative despite solid operating cash flow, while leverage is elevated (debt‑to‑equity > 38). The dividend yield is modest (0.33 %) with a low payout ratio, suggesting sustainability, but high 30‑day volatility (≈45 %) and a max drawdown of ~‑26 % add to the risk profile.
Fundamentally, the company appears overvalued: a trailing P/E of roughly 53 far exceeds the industry average of 34, and the DCF‑derived fair value (~CNY 36.9) is well below the current price. Margins are thin (gross ~13 %, operating ~6 %) and free cash flow is negative despite solid operating cash flow, while leverage is elevated (debt‑to‑equity > 38). The dividend yield is modest (0.33 %) with a low payout ratio, suggesting sustainability, but high 30‑day volatility (≈45 %) and a max drawdown of ~‑26 % add to the risk profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with bearish MACD
- Elevated short‑term volatility
- Overvaluation relative to DCF
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Longer‑term bullish trend above 200‑day SMA
- Increasing trading volume indicating potential accumulation
- Sector cyclicality and modest revenue growth
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Significant overvaluation (PE vs industry, DCF gap)
- High debt load and negative free cash flow
- Geopolitical and regulatory exposure in China
Key Metrics & Analysis
Financial Health
Revenue Growth6.00%
Profit Margin3.75%
P/E Ratio52.7
ROE5.10%
ROA2.12%
Debt/Equity38.68
P/B Ratio2.8
Op. Cash FlowCN¥5.6B
Free Cash FlowCN¥-1348350080
Industry P/E34.2
Technical Analysis
TrendBullish
RSI41.5
SupportCN¥42.70
ResistanceCN¥50.33
MA 20CN¥46.61
MA 50CN¥45.29
MA 200CN¥38.68
MACDBearish
VolumeIncreasing
Fear & Greed Index80.54
Valuation
Fair ValueCN¥36.88
GradeOvervalued
TypeBlend
Dividend Yield0.33%
Risk Assessment
Beta0.09
Volatility45.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.